FABP7 in Hepatic Macrophages Promotes Fibroblast Activation and CD4 + T‐Cell Migration by Regulating M2 Polarization During Liver Fibrosis
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index; 8 of the 14 sources its claims cite were checked for support.
Abstract
Hepatic macrophages respond to various microenvironmental signals and play a central role in maintaining hepatic homeostasis, dysregulation of which leads to various liver diseases. Fatty acid‐binding protein 7 (FABP7), an intracellular lipid chaperone for polyunsaturated fatty acids (PUFAs), is highly expressed in liver macrophages. However, the mechanisms by which FABP7 regulates hepatic macrophage activation remain unclear. Therefore, we aimed to elucidate the mechanisms underlying the effects of FABP7 on the functions of hepatic macrophages in metabolic dysfunction‐associated steatohepatitis (MASH) and liver fibrosis models. In this study, we found that FABP7‐deficient macrophages exhibited impaired M2 polarization, which reduced the fibrotic response of myofibroblasts and CD4 + T‐cell infiltration into the liver tissues in a carbon tetrachloride (CCl 4 )‐induced hepatic fibrosis model. In vitro, FABP7‐deficient macrophages exhibited decreased levels of peroxisome proliferator‐activated receptor (PPAR)‐ γ and its target genes, including C–C motif chemokine ligand (CCL)‐17 and transforming growth factor‐ β (TGF‐ β ), compared to the wild‐type (WT) macrophages post‐interleukin (IL)‐4 stimulation. However, these effects were inhibited by a PPAR γ inhibitor. IL‐4‐stimulated WT macrophages also promoted CD4 + T‐cell migration and hepatic fibroblast (TWNT‐1 hepatic stellate cell [HSC]) activation, indicated by increased mRNA levels of actin alpha 2, smooth muscle ( ACTA2 ), and collagen type I alpha 1 ( COL1A1 ); however, these effects were inhibited in FABP7‐deficient macrophages. Overall, FABP7 in hepatic macrophages modulated the crosstalk between hepatic fibroblasts and T cells by regulating M2 polarization. Therefore, regulation of hepatic macrophage function by FABP7 is a potential therapeutic target for liver fibrosis.
Overview
CoChat Summary
TL;DR
FABP7 in hepatic macrophages promotes liver fibrosis by driving M2 polarization, which in turn increases hepatic fibroblast activation and CD4+ T-cell migration. In Fabp7-deficient mice and macrophages, fibrosis-related markers, M2-associated genes, and downstream fibrotic/cell-migration effects were reduced.
Key findings
- In the CCl4-induced liver fibrosis model, Fabp7−/− mice had significantly lower collagen levels, fewer α-SMA-positive regions, and lower liver hydroxyproline than WT mice.
- Hepatic macrophages in fibrotic livers expressed more FABP7, and Fabp7−/− macrophages showed reduced M2-related gene expression (including Tgfb1, Il-10, Mrc1, Pparg1, Cd36, and Ccl17) without significant changes in M1-related genes (Tnfa, Il-1b).
- In IL-4-stimulated BMDMs, FABP7 deficiency lowered M2 markers and mediators, including Arg1, Ccl17, Tgfb1, and Pparg1; CCL17 and TGF-β production were also reduced, and PPARγ levels were lower.
- IL-4-stimulated WT BMDM-conditioned medium increased CD4+ T-cell migration and TWNT-1 hepatic stellate cell activation, whereas Fabp7−/− BMDM-conditioned medium reduced CD4+ T-cell migration and lowered TWNT-1 ACTA2 and COL1A1 mRNA.
Methods
- Male WT and Fabp7−/− C57BL/6 mice were studied in a CCl4-induced hepatic fibrosis model (16 injections over 8 weeks); a separate bone marrow chimera experiment used an HFHC diet for 26 weeks to assess MASH-related outcomes.
- Hepatic macrophages were isolated for qRT-PCR; BMDMs from WT and Fabp7−/− mice were differentiated with M-CSF and polarized with LPS or IL-4.
- Analyses included immunohistochemistry/immunofluorescence, Masson's trichrome staining, hydroxyproline assay, qRT-PCR, western blotting, ELISA, and transwell-like migration/conditioned-medium assays for CD4+ T cells and TWNT-1 HSCs.
Limitations
- The paper states that serum TGF-β was produced by both hepatic macrophages and other cells, such as endothelial cells, so serum TGF-β did not fully reflect macrophage-specific effects.
- The text makes evident that the study is largely preclinical and mechanistic, using mouse models and cell culture; direct human validation is not stated in the paper.
- The paper notes that regulatory mechanisms underlying FABP expression in macrophages remain unclear, and further studies are needed to elucidate FABP7’s role in epigenetic regulation of macrophage polarization.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Loss of fatty acid-binding protein 7 (Fabp7) inhibits liver fibrosis progression. (A–C) Representative images of Masson's trichrome (MT) staining (A), α-smooth muscle actin (α-SMA) immunostaining (B), and F4/80 immunostaining (C) in the liver tissues of wild-type (WT) and Fabp7−/− mice after carbon tetrachloride (CCl4) administration. (D) Percentage of MT (collagen)-positive areas in liver tissues (n = 5 or 6 mice/group). (E) Percentage of α-SMA-positive areas in liver tissues. (F) Hydroxyproline levels in WT and Fabp7−/− liver tissues. (G) Percentage of F4/80-positive areas in liver tissues. (H) Representative images of fluorescent immunostaining (FABP7 [green]/F4/80 [red]/4′,6-diamidino−2-phenylindole [DAPI; blue]). (I) Fabp7 mRNA levels in isolated hepatic macrophages of the WT-CT—and WT-CCl4-administered livers. Data are represented as the mean ± standard error (SE). p Values were determined via two-tailed Student's t-test (between two groups); n = 6 mice/group; ∗p < 0.05 and ∗∗p < 0.01.](https://figures.cochat.ai/paper-figures/55e1315c95544e72b2417953ad010e48/fabp7-in-hepatic-macrophages-promotes-fibroblast-activation-and-cd4-sup-sup-figure-1.jpg)
![Figure 2 Fatty acid-binding protein 7 (Fabp7)-deficient hepatic macrophages inhibit M2 polarization during fibrosis. (A) mRNA expression levels of M1/M2-polarization-related genes in isolated hepatic macrophages of wild-type (WT)- and Fabp7−/− carbon tetrachloride (CCl4)-administrated livers determined via quantitative reverse transcription-polymerase chain reaction (qRT-PCR). (B) Representative images of fluorescent immunostaining (CD206 [green]/F4/80 [red]/4′,6-diamidino-2-phenylindole [DAPI; blue]). (C) Levels of transforming growth factor (TGF)-β and CCL17 in the serum of WT and Fabp7−/− mice with or without CCl4 administration determined via enzyme-linked immunosorbent assay (ELISA). Data are represented as the mean ± standard error (SE). p Values were determined via two-tailed Student's t-test (between two groups); n = 6 mice/group; ∗p < 0.05 and ∗∗p < 0.01.](https://figures.cochat.ai/paper-figures/775aec9793fe46178a7a9d3c492b3de7/fabp7-in-hepatic-macrophages-promotes-fibroblast-activation-and-cd4-sup-sup-figure-2.jpg)




Verification
Claims the paper makes
5 Valid · 2 Not valid · 4 Not checked · 42 Own results and interpretations
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“To establish a MASH model, bone marrow chimeric mice were fed an HFHC diet (Figure S2A), considering the potential influence of brain-expressed FABP7 on HFHC diet intake [19].”
§ FABP7 in Hepatic Macrophages Promotes Fibroblast Activation and CD4+ T-Cell Migration by Regulating M2 Polarization During Liver Fibrosis > 3. Results > 3.1. FABP7 in Macrophages Promotes Liver Fibrosis
What the sources say
- Could not verifycites [19] Brunt E. M. Kleiner D. E. Wilson L. A. Belt P. Neuschwander-Tetri B. A. Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings Hepatology 2011 53 3 810 820 10.1002/hep.24127 2-s2.0-79952231349 21319198 PMC3079483 sourceExperimental — accuracy not yet measured
The Materials and Methods section describes review of adult human liver biopsies, not a mouse feeding experiment. Searches of our copy for bone marrow chimeric mice, FABP7, and HFHC diet intake found no passage addressing the claimed reason for using the mice; page numbers were not available. (LLM, conf=0.77)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, levels of M1-related genes (Tnfa and Il-1 b) were not significantly different between both cell types (Figure 2A).”
§ FABP7 in Hepatic Macrophages Promotes Fibroblast Activation and CD4+ T-Cell Migration by Regulating M2 Polarization During Liver Fibrosis > 3. Results > 3.2. Fabp7 Modulates Macrophage M2 Polarization
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Notably, FABP7 expression was enhanced in the macrophages clustered around the fibrotic area (Figure 1H).”
§ FABP7 in Hepatic Macrophages Promotes Fibroblast Activation and CD4+ T-Cell Migration by Regulating M2 Polarization During Liver Fibrosis > 3. Results > 3.1. FABP7 in Macrophages Promotes Liver Fibrosis
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Hepatic fibrosis was barely observed in the collagen immunostaining and hydroxyproline assays (Figure S4C–E).”
§ FABP7 in Hepatic Macrophages Promotes Fibroblast Activation and CD4+ T-Cell Migration by Regulating M2 Polarization During Liver Fibrosis > 3. Results > 3.1. FABP7 in Macrophages Promotes Liver Fibrosis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, no significant difference in the nonalcoholic fatty liver disease (NAFLD) activity scores (NAS) was observed between WT and Fabp7−/− BMT mice (Figure S4A,B).”
§ FABP7 in Hepatic Macrophages Promotes Fibroblast Activation and CD4+ T-Cell Migration by Regulating M2 Polarization During Liver Fibrosis > 3. Results > 3.1. FABP7 in Macrophages Promotes Liver Fibrosis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
27 more claims
Create a free account to see all 53 claims and every source verdict.
- Probably not a substantial claim. 12
- It may state two separate claims as one. 11
- The quote only partly states this claim. 1
Citations
Cites
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
Rinella, M. E., Lazarus, J. V., Ratziu, V., Francque, S. M., Sanyal, A. J., Kanwal, F., Romero, D., Abdelmalek, M. F., Anstee, Q. M., Arab, J. P., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.06.003 · Cited by 3,100 · cited 1×
“For instance, M1-polarized hepatic macrophages aggravate, whereas M2-polarized hepatic macrophages alleviate metabolic dysfunction-associated steatohepatitis (MASH), for-merlyknown as nonalcoholic steatohepatitis (NASH) [4, 5].”
Yunna, C., Mengru, H., Lei, W., & Weidong, C. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173090 · Cited by 2,454 · cited 1×
“…(IFN-γ ) induce M1 macrophages to promote in fl ammation, eliminate pathogenic microorganisms, and exert antitumor effects, whereas interleukin (IL)-4 and IL-13 induce M2 macrophages to suppress in fl ammation, tissue remodeling, angiogenesis, immune regulation, and tumor progression [2].”
Bouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P., & Neuschwander-Tetri, B. A. (2011) · Hepatology · doi:10.1002/hep.24127 · Cited by 1,251
Metabolic functions of FABPs—mechanisms and therapeutic implications
Hotamisligil, G. S., & Bernlohr, D. A. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.122 · Cited by 712 · cited 1×
“Fatty acid-binding proteins (FABPs) are intracellular chaperones of long-chain fatty acids that regulate lipid metabolism, signal transduction, and gene expression [7, 8].”
Makowski, L., Boord, J. B., Maeda, K., Babaev, V. R., Uysal, K. T., Morgan, M. A., Parker, R. A., Suttles, J., Fazio, S., Hotamisligil, G. S., et al. (2001) · Nature Medicine · doi:10.1038/89076 · Cited by 686
Metabolic reprogramming in macrophage responses
Liu, Y., Xu, R., Gu, H., Zhang, E., Qu, J., Cao, W., Huang, X., Yan, H., He, J., & Cai, Z. (2021) · Biomarker Research · doi:10.1186/s40364-020-00251-y · Cited by 641
Di Stasi, A., De Angelis, B., Rooney, C. M., Zhang, L., Mahendravada, A., Foster, A. E., Heslop, H. E., Brenner, M. K., Dotti, G., & Savoldo, B. (2009) · Blood · doi:10.1182/blood-2009-03-209650 · Cited by 533
Control of Macrophage Activation and Function by PPARs
Chawla, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.216523 · Cited by 531 · cited 1×
“PPAR γ serves as a critical transcription factor regulating intracellular lipid metabolism and controlling the expression of M2-related genes [30].”
Effects of Omega-3 Fatty Acids on Immune Cells
Gutiérrez, S., Svahn, S. L., & Johansson, M. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20205028 · Cited by 525
Lech, M., & Anders, H.-J. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.12.001 · Cited by 418
Preparation and culture of bone marrow-derived macrophages from mice for functional analysis
Toda, G., Yamauchi, T., Kadowaki, T., & Ueki, K. (2021) · STAR Protocols · doi:10.1016/j.xpro.2020.100246 · Cited by 387
Macrophage and Fibroblast Interactions in Biomaterial‐Mediated Fibrosis
Witherel, C. E., Abebayehu, D., Barker, T. H., & Spiller, K. L. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801451 · Cited by 374 · cited 2×
“TGF-β and CCL17, upregulated in M2 macrophages, are recognized for their stimulation of ECM production by fi broblasts, leading to fi brosis [1, 29].”
Wu, H., Han, Y., Rodriguez Sillke, Y., Deng, H., Siddiqui, S., Treese, C., Schmidt, F., Friedrich, M., Keye, J., Wan, J., et al. (2019) · EMBO Molecular Medicine · doi:10.15252/emmm.201910698 · Cited by 373 · cited 1×
“OA (omega-9 monounsaturated FA) treatment induces M2-like macrophages by promoting lipid droplet formation and mitochondrial FA oxidation [40].”
He, L., Jhong, J.-H., Chen, Q., Huang, K.-Y., Strittmatter, K., Kreuzer, J., DeRan, M., Wu, X., Lee, T.-Y., Slavov, N., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109955 · Cited by 354
Furuhashi, M., Fucho, R., Görgün, C. Z., Tuncman, G., Cao, H., & Hotamisligil, G. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34750 · Cited by 332 · cited 2×
“FABP5 (epidermal FABP, E-FABP, or Mal-1) is ubiquitously expressed in macrophages and controls (CTs) alternative macrophage activation by modulating the metabolism of long-chain unsaturated fatty acids [11, 13, 14].”
T Cells in Fibrosis and Fibrotic Diseases
Zhang, M., & Zhang, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01142 · Cited by 330 · cited 1×
“Th cells promote fi brotic responses [27, 28].”
Epigenetic regulation of macrophages: from homeostasis maintenance to host defense
Chen, S., Yang, J., Wei, Y., & Wei, X. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-019-0315-0 · Cited by 316 · cited 1×
“Recent studies have highlighted epigenetic regulation as a potential mechanism underlying macrophage polarization [36].”
Barron, L., & Wynn, T. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00414.2010 · Cited by 304 · cited 1×
“Th cells promote fi brotic responses [27, 28].”
GATA3: a master of many trades in immune regulation
Wan, Y. Y. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.04.002 · Cited by 248 · cited 1×
“GATA3 expression is regulated by various signaling pathways, including the IL-4-STAT6, mTOR, and Notch pathways, which are essential for the differentiation and functional regulation of T cells [34].”
Crystal Structure and Thermodynamic Analysis of Human Brain Fatty Acid-binding Protein
Balendiran, G. K., Schnütgen, F., Scapin, G., Börchers, T., Xhong, N., Lim, K., Godbout, R., Spener, F., & Sacchettini, J. C. (2000) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61478-x · Cited by 217 · cited 2×
“The distinct binding af fi nities of FABP5 and FABP7 for fatty acids [41, 45], along with the diverse expression patterns of FABP subtypes in macrophages, possibly in fl uence PPAR γ function and M2 polarization by modulating the intracellular fatty acid composition and metabolism.”
Hao, J., Yan, F., Zhang, Y., Triplett, A., Zhang, Y., Schultz, D. A., Sun, Y., Zeng, J., Silverstein, K. A. T., Zheng, Q., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2465 · Cited by 168 · cited 1×
“FABP4 is also expressed in M2-like tumor-associated macrophages and plays a critical role in pro-tumor activity by promoting the IL-6/signal transducer and activator of transcription (STAT)-3 signaling pathway in a murine breast cancer model [12].”
Altered emotional behavioral responses in mice lacking brain‐type fatty acid‐binding protein gene
Owada, Y., Abdelwahab, S. A., Kitanaka, N., Sakagami, H., Takano, H., Sugitani, Y., Sugawara, M., Kawashima, H., Kiso, Y., Mobarakeh, J. I., et al. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04855.x · Cited by 154 · cited 3×
“Previously, we demonstrated that liver macrophages exhibit high levels of FABP7 without FABP4 or FABP5 expression [15, 16].”
Self-citationYoon, Y.-S., Kim, S.-Y., Kim, M.-J., Lim, J.-H., Cho, M.-S., & Kang, J. L. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.130 · Cited by 145
Zhang, Y., Sun, Y., Rao, E., Yan, F., Li, Q., Zhang, Y., Silverstein, K. A. T., Liu, S., Sauter, E., Cleary, M. P., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2689 · Cited by 129
Fatty Acid Binding Protein: Localization and Functional Significance in the Brain
Owada, Y. (2008) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.214.213 · Cited by 122
Self-citationHou, Y., Wei, D., Zhang, Z., Guo, H., Li, S., Zhang, J., Zhang, P., Zhang, L., & Zhao, Y. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111668 · Cited by 100 · cited 2×
“FABP5 (epidermal FABP, E-FABP, or Mal-1) is ubiquitously expressed in macrophages and controls (CTs) alternative macrophage activation by modulating the metabolism of long-chain unsaturated fatty acids [11, 13, 14].”
Xu, M., Hu, J., Shen, J., Wang, M., Zhang, Q., Qu, Y., & Lu, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.025 · Cited by 97
FABP4/aP2 Regulates Macrophage Redox Signaling and Inflammasome Activation via Control of UCP2
Steen, K. A., Xu, H., & Bernlohr, D. A. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00282-16 · Cited by 97 · cited 1×
“Levels of FABP4 and FABP5, which are expressed in BMDMs [13, 24], in WT and Fabp7 − / − BMDMs were also assessed via qPCR and western blotting.”
FABP7 Protects Astrocytes Against ROS Toxicity via Lipid Droplet Formation
Islam, A., Kagawa, Y., Miyazaki, H., Shil, S. K., Umaru, B. A., Yasumoto, Y., Yamamoto, Y., & Owada, Y. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1489-2 · Cited by 93 · cited 1×
“We have previously reported that FABP7 in astrocytes participates in omega-3 PUFA (ALA) uptake and lipid droplet formation [42, 43].”
Self-citationHohoff, C., Börchers, T., Rüstow, B., Spener, F., & van Tilbeurgh, H. (1999) · Biochemistry · doi:10.1021/bi990305u · Cited by 92
FABP7 expression in normal and stab-injured brain cortex and its role in astrocyte proliferation
Sharifi, K., Morihiro, Y., Maekawa, M., Yasumoto, Y., Hoshi, H., Adachi, Y., Sawada, T., Tokuda, N., Kondo, H., Yoshikawa, T., et al. (2011) · Histochemistry and Cell Biology · doi:10.1007/s00418-011-0865-4 · Cited by 90
Self-citationDaniel, B., Nagy, G., Horvath, A., Czimmerer, Z., Cuaranta-Monroy, I., Poliska, S., Hays, T. T., Sauer, S., Francois-Deleuze, J., & Nagy, L. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky157 · Cited by 73
Yang, M., Song, L., Wang, L., Yukht, A., Ruther, H., Li, F., Qin, M., Ghiasi, H., Sharifi, B. G., & Shah, P. K. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.05.061 · Cited by 73
Macrophages in metabolic associated fatty liver disease
Alharthi, J., Latchoumanin, O., George, J., & Eslam, M. (2020) · World Journal of Gastroenterology · doi:10.3748/wjg.v26.i16.1861 · Cited by 65 · cited 1×
“For instance, M1-polarized hepatic macrophages aggravate, whereas M2-polarized hepatic macrophages alleviate metabolic dysfunction-associated steatohepatitis (MASH), for-merlyknown as nonalcoholic steatohepatitis (NASH) [4, 5].”
Eucalyptol prevents bleomycin-induced pulmonary fibrosis and M2 macrophage polarization
Rui, Y., Han, X., Jiang, A., Hu, J., Li, M., Liu, B., Qian, F., & Huang, L. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175184 · Cited by 61 · cited 1×
“TGF-β and CCL17, upregulated in M2 macrophages, are recognized for their stimulation of ECM production by fi broblasts, leading to fi brosis [1, 29].”
Regulation of macrophage functions by FABP-mediated inflammatory and metabolic pathways
Jin, R., Hao, J., Yi, Y., Sauter, E. R., & Li, B. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2021.158964 · Cited by 60
STAT6 Signaling Mediates PPARγ Activation and Resolution of Acute Sterile Inflammation in Mice
Lee, Y.-J., Kim, B.-M., Ahn, Y.-H., Choi, J. H., Choi, Y.-H., & Kang, J. L. (2021) · Cells · doi:10.3390/cells10030501 · Cited by 39
FABP7 Regulates Acetyl-CoA Metabolism Through the Interaction with ACLY in the Nucleus of Astrocytes
Kagawa, Y., Umaru, B. A., Shima, H., Ito, R., Zama, R., Islam, A., Kanno, S., Yasui, A., Sato, S., Jozaki, K., et al. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02057-3 · Cited by 37 · cited 1×
“We recently reported that FABP7 in astrocytes interacts with ATP citrate lyase in the nucleus, participating in histone acetylation [37] and that FABP7 binding to oleic acid (OA) in glioma cells modulates histone acetylation [38].”
Self-citationAbdelwahab, S. A., Owada, Y., Kitanaka, N., Iwasa, H., Sakagami, H., & Kondo, H. (2003) · Histochemistry and Cell Biology · doi:10.1007/s00418-003-0538-z · Cited by 34 · cited 1×
“Previously, we demonstrated that liver macrophages exhibit high levels of FABP7 without FABP4 or FABP5 expression [15, 16].”
Self-citationUmaru, B. A., Kagawa, Y., Ohsaki, Y., Pan, Y., Chen, C. T., Chen, D. K., Abe, T., Shil, S. K., Miyazaki, H., Kobayashi, S., et al. (2022) · FEBS Journal · doi:10.1111/febs.16672 · Cited by 31 · cited 1×
“We recently reported that FABP7 in astrocytes interacts with ATP citrate lyase in the nucleus, participating in histone acetylation [37] and that FABP7 binding to oleic acid (OA) in glioma cells modulates histone acetylation [38].”
Self-citationWang, Q.-R., Liu, S.-S., Min, J., Yin, M., Zhang, Y., Zhang, Y., Tang, X.-N., Li, X., & Liu, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115475 · Cited by 27
Miyazaki, H., Sawada, T., Kiyohira, M., Yu, Z., Nakamura, K., Yasumoto, Y., Kagawa, Y., Ebrahimi, M., Islam, A., Sharifi, K., et al. (2014) · The American Journal of Pathology · doi:10.1016/j.ajpath.2014.05.015 · Cited by 22 · cited 1×
“We also demonstrated impaired phagocytic function of liver macrophages during acute liver injury and reduced levels of liver fi brosis induced by carbon tetrachloride (CCl 4 ) in Fabp7 -de fi - cient mice compared to those in wild-type (WT) mice [17].”
Self-citationKizuka, F., Tokuda, N., Takagi, K., Adachi, Y., Lee, L., Tamura, I., Maekawa, R., Taketani, T., Tamura, H., Suzuki, T., et al. (2012) · Biology of Reproduction · doi:10.1095/biolreprod.112.099960 · Cited by 18
Self-citationXu, J., Zheng, B., Xie, C., Zhao, Y., Wu, H., Wang, Y., Guan, X., Lei, X., Liu, D., Lou, X., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115974 · Cited by 16
Cited by
Novel regulators of hepatic macrophages in liver fibrosis
Tang, X., Bai, M., Du, X., Wang, H., Liu, M., Fu, X., Zhang, H., Liang, S., & Wang, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1705503 · Cited by 12
Fatty acid binding proteins and their involvement in anxiety and mood disorders
Jones, M., Uzuneser, T. C., & Laviolette, S. R. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106952 · Cited by 6
Zheng, S., Deng, S., Yin, Y., Li, G., He, G., Li, J., He, J., He, H., Zeng, Y., Hu, W., et al. (2025) · Kidney Diseases · doi:10.1159/000548294 · Cited by 3
Wang, M., Lyu, H., Liu, Y., & Sun, Y. (2025) · Current Topics in Medicinal Chemistry · doi:10.2174/0115680266366687250730060318 · Cited by 3
Liang, T., Zhou, B., Changwen, G. U., Peng, G., Ning, X., & Huang, M. N. (2026) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-025-06617-y · Cited by 2
Metadata
- Authors
- Miyazaki, H., Wannakul, T., Yang, S., Yang, D., Karasawa, A., Shishido, A., Cao, R., Yamamoto, Y., Kagawa, Y., Kobayashi, S., Ogata, M., Maekawa, M., & Owada, Y.
- Affiliations
- Tohoku University (JP)
- The University of Melbourne (AU)
- Kanazawa Medical University (JP)
- Tohoku Medical and Pharmaceutical University (JP)
- Corresponding author
- Miyazaki, Hirofumi
- ORCID
- Venue
- Journal of Immunology Research
- Publisher
- Wiley
- Published
- 2025-01
- Volume
- 2025
- Issue
- 1
- Pages
- 6987981-6987981
- ISSN
- 2314-7156 (ISSN-L)
- 2314-8861
- PMC
- PMC11865460
- OpenAlex
- W4407798196
- Cited by
- 9
- References
- 45
- Citations by year
- 2026: 4 · 2025: 5
- FWCI
- 4.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor, 49 d)
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
- Locations
- Journal of Immunology Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by)
- Funders
- Japan Society for the Promotion of Science (20K16103, 18K14998, 23K24783)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- FABP7, hepatic macrophages, liver fibrosis, M2 macrophage polarization, hepatic stellate cells, fibroblast activation, CD4+ T cell migration, PPARγ, CCL17, TGF-beta, IL-4, nonalcoholic steatohepatitis, carbon tetrachloride, ACTA2, COL1A1
- MeSH terms
- Animals, Carbon Tetrachloride, Cell Movement, Disease Models, Animal, Fibroblasts, Humans, Liver, Liver Cirrhosis, Macrophage Activation, Macrophages, Male, Mice, Inbred C57BL, CD4-Positive T-Lymphocytes, Mice, Knockout, PPAR gamma, Fatty Acid-Binding Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.